Boston Scientific’s Ekos System Compared With Mechanical Thrombectomy in REAL-PE Study
October 24, 2023—Boston Scientific announced that data from the REAL-PE study demonstrated that patients treated for pulmonary embolism (PE) with the company’s Ekos endovascular system had lower rates of adverse events, including statistically significant lower rates of major bleeding, within 7 days after their procedure compared to the Inari FlowTriever system (Inari Medical, Inc).
